2019
DOI: 10.21769/bioprotoc.3392
|View full text |Cite
|
Sign up to set email alerts
|

Reconstituting Breast Tissue with Organotypic Three-dimensional Co-culture of Epithelial and Stromal Cells in Discontinuous Extracellular Matrices

Abstract: Co-culture systems utilizing reconstituted or synthetic extracellular matrix (ECM) and micropatterning techniques have enabled the reconstruction of surface epithelial tissues. This technique has been utilized in the regeneration, disease modeling and drug screening of the surface epithelia, such as the skin and esophagus. On the other hand, the reconstruction of glandular epithelia would require more intricate ECM organizations. Here we describe a protocol for a novel three-dimensional organotypic co-culture … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
11
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(11 citation statements)
references
References 15 publications
0
11
0
Order By: Relevance
“…#2301) supplemented with 1% Fibroblast Growth Supplement (FGS, ScienCell Research Laboratories, Carlsbad, CA, USA, Cat. #2352) and 1% penicillin/streptomycin as described [ 24 ].…”
Section: Methodsmentioning
confidence: 99%
See 4 more Smart Citations
“…#2301) supplemented with 1% Fibroblast Growth Supplement (FGS, ScienCell Research Laboratories, Carlsbad, CA, USA, Cat. #2352) and 1% penicillin/streptomycin as described [ 24 ].…”
Section: Methodsmentioning
confidence: 99%
“…Cultures were maintained for 10–21 days with addition of fresh medium on alternate days [ 33 ]. For 3D mono-culture of mammary fibroblasts (MFs), cells were grown in Matrigel: collagen I (1:1) mixture in the same manner as 3D co-culture (see below) [ 24 ]. To determine the effects of the inhibition of NO production, 3D cultures were kept under the treatment of 2.5 mM L-NAME (NOS inhibitor, N ω -Nitro-L-arginine methyl ester hydrochloride, Sigma-Aldrich, St. Louis, MO, USA), vehicle control (PBS) or NO synthase agonist L-arginine (2.5 mM) for 2–3 weeks with medium change every other day [ 34 ].…”
Section: Methodsmentioning
confidence: 99%
See 3 more Smart Citations